Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered1H NMR spectroscopy

Quantification of HDL Particle Concentration by Calibrated Ion Mobility Analysis

(2014) P. M. Hutchins et al.   CLINICAL CHEMISTRY

A Comparison of the Theoretical Relationship between HDL Size and the Ratio of HDL Cholesterol to Apolipoprotein A-I with Experimental Results from the Women's Health Study

(2013) N. A. Mazer et al.   CLINICAL CHEMISTRY

Association of Apolipoprotein B and Nuclear Magnetic Resonance Spectroscopy-Derived LDL Particle Number with Outcomes in 25 Clinical Studies: Assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices

(2013) T. G. Cole et al.   CLINICAL CHEMISTRY

Update on the detection and treatment of atherogenic low-density lipoproteins

(2013) Allan Sniderman et al.   Current Opinion in Endocrinology Diabetes and Obesity

High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis

(2012) P. Wurtz et al.   EUROPEAN HEART JOURNAL

High-Density Lipoprotein Cholesterol and Particle Concentrations, Carotid Atherosclerosis, and Coronary Events

(2012) Rachel H. Mackey et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Human serum/plasma lipoprotein analysis by NMR: Application to the study of diabetic dyslipidemia

(2012) Roger Mallol et al.   PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY

Clinical applications of advanced lipoprotein testing in diabetes mellitus

(2011) Danyaal S Moin et al.   Clinical Lipidology

Clinical implications of discordance between low-density lipoprotein cholesterol and particle number

(2011) James D. Otvos et al.   Journal of Clinical Lipidology

Surface fitting of 2D diffusion-edited 1H NMR spectroscopy data for the characterisation of human plasma lipoproteins

(2011) Roger Mallol et al.   Metabolomics

High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism

(2009) Pasi Soininen et al.   ANALYST

Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices

(2009) J. H. Contois et al.   CLINICAL CHEMISTRY

In Reply

(2008) M. P. Caulfield et al.   CLINICAL CHEMISTRY

Concerns Regarding Lipoprotein Particle Measurement by Ion Mobility Analysis

(2008) J. D. Otvos et al.   CLINICAL CHEMISTRY

Direct Determination of Lipoprotein Particle Sizes and Concentrations by Ion Mobility Analysis

(2008) M. P. Caulfield et al.   CLINICAL CHEMISTRY

Lipoprotein Management in Patients With Cardiometabolic Risk

(2008) John D. Brunzell et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The search for new cardiovascular biomarkers

(2008) Robert E. Gerszten et al.   NATURE